-
-
-
-
-
-
-
Barclays Starts Alpha Tau Medical Ltd. (DRTS) at Overweight
-
-
-
-
-
-
-
Alpha Tau reports 100% disease control in pancreatic cancer trials
-
-
-
-
-
-
-
Alpha Tau Medical Ltd. (DRTS) PT Raised to $12 at H.C. Wainwright
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS)
-
-
-
-
-
-
-
Alpha Tau Medical (DRTS) Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT for Patients with Recurrent Glioblastoma Multiforme
-
-
-
-
443,977 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

